Serial Number
99070993
Owner
Myriad Genetics, Inc.Attorney
Joyce M. FerraroFirst Use Date
May 1, 2024
Filing Date
Mar 6, 2025
MYRIAD ONCOLOGY Trademark
Serial Number: 99070993
Trademark Classes
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Correspondence Address
Joyce M. Ferraro Fross Zelnick Lehrman & Zissu, P.C.
151 West 42nd Street, 17th Floor
New York, NY 10036
United States
Trademark Details
Filing Date
March 6, 2025
Registration Date
Not Registered
First Use Anywhere
May 1, 2024
First Use in Commerce
May 1, 2024
Published for Opposition
January 20, 2026
Goods & Services
Medical test kit related to oncology comprising specimen collection containers in the nature of tubes for the collection of bodily fluids containing cell-free DNA, printed instructions and test forms, materials for transmitting specimens in the nature of envelopes, cardboard boxes, and plastic bags all in the medical field, and printed user information inserts being forms
Medical testing services related to oncology; genetic and genomic testing related to oncology for medical purposes; genetic testing for medical purposes; genetic testing services for diagnostic or treatment purposes; genetic counseling; medical diagnostic testing, monitoring, and reporting services; providing medical diagnostic services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories and medical diagnostic testing; medical testing, namely, providing reference and clinical laboratory tests that detect, classify, analyze, and evaluate gene mutations, gene variants, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and for use in evaluating and selecting therapy or treatment regimens; medical testing services for evaluating and selecting therapy or treatment regimens, prognosing disease, predicting disease progression or disease severity, identifying predisposition to developing disease, evaluating the efficacy or toxicity of medical treatments, and identifying risk factors of disease, molecular profiles associated with successful therapies or treatment regimens, and for classifying disease progression or severity; medical diagnostic testing for the detection of cancer to assess the presence or absence of residual disease; health assessment services; providing personalized healthcare and medical information, namely, providing medical information and reports; providing medical information, consultancy and advisory services; health evaluation services, namely, performing health assessments and health screening for purposes of determining medical risks and further testing
Providing online publications, namely, questionnaires for medical screening for diagnostic or treatment purposes
Providing temporary use of non-downloadable software for use in medical screening for diagnostic or treatment purposes; Software as a service (SAAS) services featuring software for use in medical screening for diagnostic or treatment purposes
